Showing results (11-20 of 127) with videos related to
Sort By:
Pageof 13
Trends in Molecular Medicine|June 18, 2002
Altered acetylation in polyglutamine disease: an opportunity for therapeutic intervention?J Paul Taylor, Kenneth H FischbeckNature Reviews. Genetics|October 6, 2005
Therapeutics development for triplet repeat expansion diseasesNicholas A Di Prospero, Kenneth H FischbeckTrends in Neurosciences|February 16, 2010
GARS axonopathy: not every neuron's cup of tRNAWilliam W Motley, Kevin Talbot, Kenneth H FischbeckScience (New York, N.Y.)|June 18, 2002
Toxic proteins in neurodegenerative diseaseJ Paul Taylor, John Hardy, Kenneth H FischbeckNeuron|April 19, 2014
Muscle matters in Kennedy's diseaseCarlo Rinaldi, Laura C Bott, Kenneth H FischbeckNeuro-Degenerative Diseases|February 14, 2012
Neurogenic and myogenic contributions to hereditary motor neuron diseaseKatherine V Bricceno, Kenneth H Fischbeck, Barrington G BurnettJournal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN|February 20, 2004
Spinal muscular atrophy in the neonateJennifer A Markowitz, Mindy B Tinkle, Kenneth H FischbeckBiochemistry and Biophysics Reports|November 11, 2017
The polyglutamine-expanded androgen receptor has increased DNA binding and reduced transcriptional activitySergey Belikov, Laura C Bott, Kenneth H Fischbeck, et al.ACS Chemical Biology|April 21, 2016
Inforna 2.0: A Platform for the Sequence-Based Design of Small Molecules Targeting Structured RNAsMatthew D Disney, Audrey M Winkelsas, Sai Pradeep Velagapudi, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 16, 2020
Disease mechanism, biomarker and therapeutics for spinal and bulbar muscular atrophy (SBMA)Atsushi Hashizume, Kenneth H Fischbeck, Maria Pennuto, et al.Pageof 13